RYTM ▼ -2.5% - Rhythm Pharmaceuticals, Inc.
$RYTM - Rhythm Pharmaceuticals Announces Commercial Launch of IMCIVREE® (setmelanotide) in Japan for Patients with Acquired Hypothalamic Obesity
13-OCT-2026 07:30 PM ET
Share this post
More filings for $RYTM
RYTM - Rhythm Pharmaceuticals, Inc. - SEC Filing Update (13-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 13, 2026RYTM ▼ -0.0% - Rhythm Pharmaceuticals, Inc.Sep 22, 2026RYTM ▲ +0.4% - Rhythm Pharmaceuticals, Inc.Sep 10, 2026
View full $RYTM filing history →💬 Comments
Loading comments…
Leave a comment